arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Profound Medical Corp.

PROF

$7.41 ▼ -0.51 (-6.50%) at close

15 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

Profound Medical Corp. faces fundamental challenges with weakness in Return on Common Equity (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $269.0M

Dividend Yield —

Revenue Growth 103.6% ↗

Op. Margin -150.3% ↘

ROIC -12.6% ↘

FCF / Share $-0.24

Trailing P/E 39.0x

Price / Book 4.5x

FCF Yield —

Debt / Equity 0.08

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.34M

↑ +103.6% —

Net Income Profit after all expenses

$-7.05M

↑ +34.2% —

Operating Margin Operating profit as % of sales

-150.3%

↓ -21.9% 0th

FCF / Share Free cash flow per share

$-0.24

↑ +14.2% —

Long-Term Debt Long-term obligations

$4.50M

— +0.1% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Revenue Growth YoY (%)	103.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1195%)	43.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+439%)	86.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+984%)	-1.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-112%)	82.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+927%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-47.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-31.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	85.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	34.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-65.3% Weak → Weak Stable Year-over-year change in net income	-62.9% Weak → Weak Stable Year-over-year change in net income	-62.9% Weak Weak Year-over-year change in net income	-62.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	14.2% Fair ↑ Fair Improving Year-over-year change in free cash flow	—	-14.8% Weak ↑ Weak Improving Year-over-year change in free cash flow	-79.7% Weak Weak Year-over-year change in free cash flow	-47.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Operating Margin (%) (%)	-150.3% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1102%)	-123.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-922%)	-168.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1223%)	—	-426.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2940%)	-199.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1432%)	-317.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2218%)	-351.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2441%)	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	-132.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1201%)	-136.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1240%)	-202.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1790%)	-485.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4142%)	-409.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3510%)	-118.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1087%)	-232.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2038%)	-294.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2557%)	-457.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3913%)	—	—	—	—	—	—
FCF Margin (%) (%)	-160.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-109.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-181.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-316.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-140.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-241.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-278.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-314.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	1.22x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Return on Invested Capital (%)	-12.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-17.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-11.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-12.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-33.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-322%)	-27.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-8.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-21.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-16.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-14.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Debt to Equity (x)	0.08x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	0.07x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.14x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	0.11x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	0.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	—	—	—	0.23x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-62%)	0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	—	—	—	—
Interest Coverage (x)	-100.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-86.69x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-74.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-67.68x Weak Weak Operating income divided by interest expense Optimal: > 5x	-107.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-13.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-45.79M	$-55.22M	$-20.35M	$-30.73M	$-41.95M	$-50.25M	—	—	—	$-19.11M	$7.17M	—	—	—	—
Debt / EBITDA (x)	-0.57x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.62x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.51x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.41x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.57x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Revenue per Share (USD)	$0.15	—	$0.18	$0.07	$0.09	—	$0.12	$0.09	$0.06	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.19	$0.27	$0.26	$0.52	$0.36	$0.18	$0.38	$0.28	$0.27	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.24	—	$-0.32	$-0.46	$-0.28	—	$-0.28	$-0.25	$-0.19	—	—	—	—	—	—
Book Value per Share (USD)	$1.64	$1.83	$1.06	$1.31	$1.69	$2.01	$1.25	$1.59	$1.87	$1.46	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.64	$1.83	$1.06	$1.31	$1.69	$2.01	$1.25	$1.59	$1.87	$1.46	—	—	—	—	—
Basic Weighted Avg Shares (shares)	36.30M	—	30.10M	30.05M	30.04M	—	24.53M	24.44M	24.30M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Working Capital (USD)	$58.92M	$70.01M	$31.59M	$43.09M	$54.62M	$62.50M	—	—	—	$35.53M	—	—	—	—	—
LT Debt (USD)	$4.50M	$4.50M	$4.48M	$4.46M	$4.49M	$4.66M	—	—	—	$7.10M	$7.17M	—	—	—	—
Total Equity (USD)	$59.42M	$66.43M	$32.14M	$39.26M	$50.79M	$60.42M	$30.72M	$38.90M	$45.52M	$31.22M	$52.60M	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 40-F ↗	Q4 FY2020 Dec 31, 2020 40-F ↗	Q4 FY2019 Dec 31, 2019 40-F ↗	Q4 FY2018 Jan 1, 2019 40-F ↗
Sales/Revenue/Turnover (USD)	$5.34M	$5.98M	$5.29M	$2.21M	$2.62M	$4.18M	$2.83M	$2.23M	$1.44M	—	—	—	—	—	—
Depreciation Expense (USD)	$93.00K	$62.00K	$93.00K	$102.00K	$116.00K	$160.00K	$164.00K	$184.00K	$199.00K	—	—	—	—	—	—
Net Income, GAAP (USD)	$-7.05M	$-8.18M	$-10.72M	$-10.72M	$-10.72M	$-4.95M	$-6.58M	$-6.58M	$-6.58M	—	—	—	—	—	—
Operating Cash Flow (USD)	$-8.58M	$-6.57M	$-9.61M	$-13.74M	$-8.28M	$-5.88M	$-6.83M	$-6.22M	$-4.53M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 15 quarters

Profound Medical Corp.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PROF with peers